Results 71 to 80 of about 4,063 (129)

Targeted Inhibition of the Epidermal Growth Factor Receptor and Mammalian Target of Rapamycin Signaling Pathways in Olmsted Syndrome.

open access: yesJAMA Dermatol, 2020
Zhang A   +12 more
europepmc   +1 more source

Use of Epidermal Growth Factor Receptor Inhibitor Erlotinib to Treat Palmoplantar Keratoderma in Patients With Olmsted Syndrome Caused by TRPV3 Mutations.

open access: yesJAMA Dermatol, 2020
Greco C   +7 more
europepmc   +1 more source

A novel mutation in TRPV3 gene causes atypical familial Olmsted syndrome. [PDF]

open access: yesSci Rep, 2016
Ni C   +8 more
europepmc   +1 more source

Exome sequencing reveals mutations in TRPV3 as a cause of Olmsted syndrome. [PDF]

open access: yesAm J Hum Genet, 2012
Lin Z   +20 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy